| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/26/2000 | EP1021721A1 Assays for tsh receptor autoantibodies |
| 07/26/2000 | EP1021556A1 Assay using marked microbial host cell strains |
| 07/26/2000 | EP1021540A1 Human progesterone receptor complex p23-like protein |
| 07/26/2000 | EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 07/26/2000 | EP1021536A2 Mammalian genes involved in viral infection and tumor suppression |
| 07/26/2000 | EP1021528A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 07/26/2000 | EP1021465A2 Gfp-annexin fusion proteins |
| 07/26/2000 | EP1021464A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 07/26/2000 | EP1021460A1 Laminins and uses thereof |
| 07/26/2000 | EP1021202A1 Immunogenic peptides from the hpv e7 protein |
| 07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 07/26/2000 | EP0832134B1 Anti-allergy bispecific molecules |
| 07/26/2000 | EP0786084A4 Method for screening compositions |
| 07/26/2000 | EP0769054B1 Immunomodulators |
| 07/26/2000 | CN1261104A Human oxido-reductase subunit and its coding sequence, preparing process and application |
| 07/26/2000 | CN1261103A Human targeting glycogen protein,and its coding sequence, preparing process and application |
| 07/25/2000 | US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage |
| 07/25/2000 | US6093796 Recombinant hK2 polypeptide |
| 07/25/2000 | US6093545 Contacting the sample with nucleic acid probe or primer and detecting hybridization to the target nucleic acid; diagnosis of nervous system disorders including eating and sleep disorders, irritable bowel and glandular disorders |
| 07/25/2000 | US6093540 Method for diagnosing a disorder characterized by expression of a BAGE tumor rejection antigen precursor |
| 07/25/2000 | US6093534 Monoclonal antibody specifically recognizing adeno-associated virus cap protein |
| 07/25/2000 | US6093395 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production |
| 07/25/2000 | CA2160131C New bacillus thuringiensis strains and their insecticidal proteins |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/25/2000 | CA2094611C Hiv immunotherapeutics |
| 07/25/2000 | CA2015377C Autoantibodies which enhance the rate of a chemical reaction |
| 07/25/2000 | CA2015077C A yeast cell of the genus schwanniomyces |
| 07/25/2000 | CA2010256C Protein anti-cancer agent |
| 07/20/2000 | WO2000042561A2 Oligonucleotide mediated nucleic acid recombination |
| 07/20/2000 | WO2000042560A2 Methods for making character strings, polynucleotides and polypeptides |
| 07/20/2000 | WO2000042203A2 Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells |
| 07/20/2000 | WO2000042191A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/20/2000 | WO2000042188A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | WO2000042185A1 Methods for regulating the stability of recombinant proteins and products useful therein |
| 07/20/2000 | WO2000042179A2 Complex-forming proteins |
| 07/20/2000 | WO2000042175A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | WO2000042172A2 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | WO2000042165A2 Bone marrow-specific protein |
| 07/20/2000 | WO2000042074A1 Anti-ccr4 antibodies and methods of use therefor |
| 07/20/2000 | WO2000042072A2 Polypeptide variants with altered effector function |
| 07/20/2000 | WO2000042069A1 Bone stimulating factor |
| 07/20/2000 | WO2000042066A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 07/20/2000 | WO2000042062A1 Novel depsipeptide compound |
| 07/20/2000 | WO2000041731A1 Reverse gene therapy |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041516A2 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | WO2000031141B1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 07/20/2000 | WO2000026230A8 Low allergenic protein variants |
| 07/20/2000 | WO2000021979A3 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 07/20/2000 | WO2000020590A3 G-protein coupled receptor proteins |
| 07/20/2000 | WO2000017358A3 Human chaperone proteins |
| 07/20/2000 | WO2000017235A3 Cytokine receptor zalpha11 |
| 07/20/2000 | WO2000015772A3 Recombinant protein production in urine |
| 07/20/2000 | WO2000012140A8 Method for labeling biopolymers using isotopes |
| 07/20/2000 | WO2000004149A3 Compositions and methods for therapy and diagnosis of prostate cancer |
| 07/20/2000 | WO2000003012A9 Expression of eukaryotic peptides in plant plastids |
| 07/20/2000 | WO2000002897A9 Delta cleavage products and methods based thereon |
| 07/20/2000 | WO1999067360A3 Media and methods for expansion of erythroid stem cells for the production of hemoglobin |
| 07/20/2000 | WO1999054353A3 Human nucleic acid sequences of normal uterus tissue |
| 07/20/2000 | WO1999053046A9 Noncloning technique for expressing a gene of interest |
| 07/20/2000 | CA2361204A1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2359504A1 Novel compounds |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2359345A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | CA2359132A1 Bone marrow-specific protein |
| 07/20/2000 | CA2359067A1 Polypeptide variants with altered effector function |
| 07/20/2000 | CA2358908A1 Bone stimulating factor |
| 07/20/2000 | CA2358748A1 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | CA2358693A1 Anti-ccr4 antibodies and methods of use therefor |
| 07/20/2000 | CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | CA2320714A1 Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| 07/20/2000 | CA2320697A1 Oligonucleotide mediated nucleic acid recombination |
| 07/19/2000 | EP1020523A2 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 07/19/2000 | EP1020522A1 Natural human antibody |
| 07/19/2000 | EP1020516A2 Leptospira vaccine antigens for the prevention of leptospirosis |
| 07/19/2000 | EP1019513A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases |
| 07/19/2000 | EP1019510A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 07/19/2000 | EP1019508A1 Tnf-related death ligand |
| 07/19/2000 | EP1019506A1 101 human secreted proteins |
| 07/19/2000 | EP1019504A1 Isoforms of the human vitamin d receptor |
| 07/19/2000 | EP1019503A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 07/19/2000 | EP1019502A2 Human orphan receptor ntr-1 |
| 07/19/2000 | EP1019442A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 07/19/2000 | EP1019439A1 Soluble single-chain t-cell receptor proteins |
| 07/19/2000 | EP1019436A1 Acquired resistance npr genes and uses thereof |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019073A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP0871354A4 Hypersensitive response induced resistance in plants |
| 07/19/2000 | EP0527815B1 Hepatitis c virus epitopes |
| 07/19/2000 | CN1260837A Plant GRAB proteins |
| 07/19/2000 | CN1260833A LAG-3 splice variants |
| 07/19/2000 | CN1054609C Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor |
| 07/19/2000 | CN1054544C Polypeptide vaccine for mouth and hoof disease of domestic animal and preparation method |
| 07/18/2000 | US6090931 Screening for nucleotide sequences coding an adjusted bacterial crystal protein poison; replacing nucleotide sequences, producing adjusted crystal protein poison, evaluating range of sensitivity |
| 07/18/2000 | US6090929 Polynucleotide coding a cyclic adenosine monophosphate-dependent kinase binding polypeptide; for recombinant production of the kinase binding domain polypeptides; for treatment of myasthenia gravis |